世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035865

骨格異形成症の世界市場規模調査・予測:タイプ別、治療別、地域別の分析(2022年〜2029年)

Bizwit Research & Consulting LLP

Global Skeletal Dysplasia Market Size Study & Forecast, by Type (X-linked hypophosphatemia, Hypophosphatasia, Achondroplasia, Fibrodysplasia ossificans progressive, Multiple osteochondromas, Others), by Treatment (Medication, Surgery, Others) and Regional Analysis, 2022-2029

発刊日 2023/05/09

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000035865

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

骨格異形成症は、450以上の異なる形態で現れる希少な疾患で、骨や軟骨の成長と発達に影響を及ぼします。この症状は非常に重く、成人の異常発達や新生児の死亡に至ることもあります。骨系統疾患は、診断が難しい稀な疾患です。成長が遅い、頭が大きい、上腕や脚が短いなどの奇形、骨のねじれ、関節炎、関節痛などは、その兆候のいくつかです。乳幼児に深刻な影響を与える疾患であり、早期発見が認識につながります。この疾患は、先祖から受け継いだり、成長過程で変化したりする遺伝子の異常が原因です。変異した遺伝子を特定することも問題です。そのため、大手企業はこの遺伝性疾患の治療法の研究開発に大きな投資をしています。骨格形成不全の有病率の上昇、新薬の商業化、パイプライン製品の存在、ヘルスケア分野への政府支出の増加といった主要な要因が、予測期間中の市場成長をサポートすると予想されます。

さらに、骨格異形成症の有病率の大幅な上昇と骨格異形成症治療の採用の増加は、予測期間中に市場に有利な需要を生み出すと予測されます。例えば、UpToDateに掲載されたジャーナルによると、骨格異形成症の有病率は、毎日、世界中の新生児10万人あたり2.4人になると予測されています。超音波スクリーニングによると、妊婦10万人あたり7.5人の骨格異形成症の患者がいます。さらに、骨格異形成症治療のための臨床試験や共同研究の増加が、市場に有利な機会をもたらすと予想されています。しかし、厳しい規制規則と高コストが、2022年から2029年の予測期間を通じて市場の成長を阻害しています。

世界の骨格異形成症市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、および世界のその他の地域含まれます。北アメリカは、大手製薬会社やバイオ製薬会社の存在、確立されたヘルスケアインフラの存在、高い購買力、骨系統疾患の普及率の上昇などにより、市場シェアにおいて世界の主要な地域となっています。一方、アジア太平洋地域は、小児人口の増加、軟骨異形成、タナトフォリック異形成、骨形成不全、低軟骨異形成などの骨格異形成症の有病率の増加などの要因により、予測期間中に最も高い成長率を示すと予想され、アジア太平洋地域の骨格異形成症市場に有利な成長見通しを創出します。

調査範囲

  • 調査企業
    ➣ Amgen Inc.
    ➣ AstraZeneca plc
    ➣ Cipla Ltd
    ➣ Merck KGaA
    ➣ Ascendis pharma a/s
    ➣ F. Hoffmann-La Roche AG
    ➣ Eli Lilly and Company
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Pfizer, Inc.
    ➣ Biomarin Pharmaceuticals Inc.
  • 調査対象年
    ➣ 履歴データ - 2019-2020-2021
    ➣ 推定基準年 - 2021
    ➣ 予測期間 - 2022-2029

この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。

このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。

  • 市場セグメント
    ➣ タイプ別
      ◇ X連鎖性低リン酸血症
      ◇ 低リン酸血症
      ◇ 軟骨無形成症
      ◇ 進行性骨化性線維異形成症
      ◇ 多発性骨軟骨腫
      ◇ その他
    ➣ 治療別
      ◇ 薬物療法
      ◇ 外科手術
      ◇ その他
    ➣ 地域別
      ◇ 北アメリカ
       ✓ アメリカ
       ✓ カナダ
      ◇ ヨーロッパ
       ✓ イギリス
       ✓ ドイツ
       ✓ フランス
       ✓ スペイン
       ✓ イタリア
       ✓ その他のヨーロッパ
      ◇ アジア太平洋地域
       ✓ 中国
       ✓ インド
       ✓ 日本
       ✓ オーストラリア
       ✓ 韓国
       ✓ その他のAPAC
      ◇ ラテンアメリカ
       ✓ ブラジル
       ✓ メキシコ
       ✓ その他のラテンアメリカ
      ◇ 世界のその他の地域

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Skeletal Dysplasia Market, by Region, 2019-2029 (USD Billion)
1.2.2. Skeletal Dysplasia Market, by Type, 2019-2029 (USD Billion)
1.2.3. Skeletal Dysplasia Market, by Treatment, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Skeletal Dysplasia Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Skeletal Dysplasia Market Dynamics
3.1. Skeletal Dysplasia Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing paediatric population
3.1.1.2. Increase in prevalence of skeletal dysplasia.
3.1.1.3. Growing government expenditure on healthcare
3.1.2. Market Challenges
3.1.2.1. Strict regulatory rules and high cost
3.1.3. Market Opportunities
3.1.3.1. Rising number of clinical trials and collaborative research for skeletal dysplasia treatment

Chapter 4. Global Skeletal Dysplasia Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Skeletal Dysplasia Market, by Type
6.1. Market Snapshot
6.2. Global Skeletal Dysplasia Market by Type, Performance - Potential Analysis
6.3. Global Skeletal Dysplasia Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Skeletal Dysplasia Market, Sub Segment Analysis
6.4.1. X-linked hypophosphatemia
6.4.2. Hypophosphatasia
6.4.3. Achondroplasia
6.4.4. Fibrodysplasia ossificans progressive
6.4.5. Multiple osteochondromas
6.4.6. Others

Chapter 7. Global Skeletal Dysplasia Market, by Treatment
7.1. Market Snapshot
7.2. Global Skeletal Dysplasia Market by Treatment, Performance - Potential Analysis
7.3. Global Skeletal Dysplasia Market Estimates & Forecasts by Treatment 2019-2029 (USD Billion)
7.4. Skeletal Dysplasia Market, Sub Segment Analysis
7.4.1. Medication
7.4.2. Surgery
7.4.3. Others

Chapter 8. Global Skeletal Dysplasia Market, Regional Analysis
8.1. Skeletal Dysplasia Market, Regional Market Snapshot
8.2. North America Skeletal Dysplasia Market
8.2.1. U.S. Skeletal Dysplasia Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Treatment breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Skeletal Dysplasia Market
8.3. Europe Skeletal Dysplasia Market Snapshot
8.3.1. U.K. Skeletal Dysplasia Market
8.3.2. Germany Skeletal Dysplasia Market
8.3.3. France Skeletal Dysplasia Market
8.3.4. Spain Skeletal Dysplasia Market
8.3.5. Italy Skeletal Dysplasia Market
8.3.6. Rest of Europe Skeletal Dysplasia Market
8.4. Asia-Pacific Skeletal Dysplasia Market Snapshot
8.4.1. China Skeletal Dysplasia Market
8.4.2. India Skeletal Dysplasia Market
8.4.3. Japan Skeletal Dysplasia Market
8.4.4. Australia Skeletal Dysplasia Market
8.4.5. South Korea Skeletal Dysplasia Market
8.4.6. Rest of Asia Pacific Skeletal Dysplasia Market
8.5. Latin America Skeletal Dysplasia Market Snapshot
8.5.1. Brazil Skeletal Dysplasia Market
8.5.2. Mexico Skeletal Dysplasia Market
8.5.3. Rest of Latin America Skeletal Dysplasia Market
8.6. Rest of The World Skeletal Dysplasia Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Amgen Inc
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. AstraZeneca plc
9.2.3. Cipla Ltd
9.2.4. Merck KGaA
9.2.5. Ascendis pharma a/s
9.2.6. F. Hoffmann-La Roche AG
9.2.7. Eli Lilly and Company
9.2.8. Teva Pharmaceutical Industries Ltd.
9.2.9. Pfizer, Inc
9.2.10. Biomarin Pharmaceuticals Inc

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES
TABLE 1. Global Skeletal Dysplasia Market, report scope
TABLE 2. Global Skeletal Dysplasia Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Skeletal Dysplasia Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Skeletal Dysplasia Market estimates & forecasts by Treatment 2019-2029 (USD Billion)
TABLE 5. Global Skeletal Dysplasia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Skeletal Dysplasia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Skeletal Dysplasia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Skeletal Dysplasia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Skeletal Dysplasia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Skeletal Dysplasia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Skeletal Dysplasia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Skeletal Dysplasia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Skeletal Dysplasia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Skeletal Dysplasia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Skeletal Dysplasia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Skeletal Dysplasia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Skeletal Dysplasia Market
TABLE 70. List of primary sources, used in the study of global Skeletal Dysplasia Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES
FIG 1. Global Skeletal Dysplasia Market, research methodology
FIG 2. Global Skeletal Dysplasia Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Skeletal Dysplasia Market, key trends 2021
FIG 5. Global Skeletal Dysplasia Market, growth prospects 2022-2029
FIG 6. Global Skeletal Dysplasia Market, porters 5 force model
FIG 7. Global Skeletal Dysplasia Market, pest analysis
FIG 8. Global Skeletal Dysplasia Market, value chain analysis
FIG 9. Global Skeletal Dysplasia Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Skeletal Dysplasia Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Skeletal Dysplasia Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Skeletal Dysplasia Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Skeletal Dysplasia Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Skeletal Dysplasia Market, regional snapshot 2019 & 2029
FIG 15. North America Skeletal Dysplasia Market 2019 & 2029 (USD Billion)
FIG 16. Europe Skeletal Dysplasia Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Skeletal Dysplasia Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Skeletal Dysplasia Market 2019 & 2029 (USD Billion)
FIG 19. Global Skeletal Dysplasia Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

この商品のレポートナンバー

0000035865

TOP